Skip to content
Tulburări de somn

Tratamente Tulburări de somn

Explorati tratamentele tulburări de somn disponibile. Toate includ analiza unui medic independent din UE, medicamente originale din farmacii autorizate si livrare expres discreta.

2026-04-12 Tratamente

Interested in Tulburări de somn?

Complete a confidential health assessment reviewed by an independent EU-registered doctor.

Start Assessment

Sleep disorder tratamente în Europa

Sleep disorders represent a significant and growing public health burden across the European Union. Insomnia — characterised by persistent difficulty falling asleep, staying asleep, or waking too early, with consequent daytime impairment — is estimated to affect between 10% and 30% of the adult European population. When accounting for sub-threshold sleep disturbance, the figure is considerably higher.

The consequences of inadequate sleep extend well beyond fatigue. Chronic insomnia is associated with increased risk of cardiovascular disease, metabolic disorders including type 2 diabetes, depression, anxiety, and impaired cognitive function. Occupational and road safety risks associated with sleep deprivation impose significant societal costs.

Sleep disorders exist on a spectrum. Transient or short-term insomnia, often related to stress, travel, or life events, frequently resolves without pharmacological intervention. Chronic insomnia — defined as occurring at least three nights per week for at least three months — is a recognised medical condition warranting clinical evaluation and, where appropriate, treatment.

International clinical guidelines, including those from the European Sleep Research Society, recommend cognitive behavioural therapy for insomnia (CBT-I) as the first-line treatment for chronic insomnia. Pharmacological treatments may be appropriate for short-term management or when CBT-I is unavailable or insufficient. Prescription sleep medications include melatonin (approved for certain indications), and sedative-hypnotic agents (Z-drugs) such as zopiclone and zolpidem.

It is important that any prescription for sleep medication be accompanied by assessment for underlying causes, including sleep apnoea, depression, anxiety, or medication side effects. A qualified, independent doctor is best placed to determine the appropriate treatment pathway.

Tratamente disponibile

The following medications may be available for sleep disorders through EU-registered doctors. This comparison is provided for informational purposes only.

MedicationActive IngredientClassTypical Use
Melatonin (prescription)MelatoninChronobiotic hormoneCircadian rhythm disorders, older adults with insomnia
ZopicloneZopicloneZ-drug (sedative-hypnotic)Short-term insomnia
ZolpidemZolpidem tartrateZ-drug (sedative-hypnotic)Short-term insomnia

Key distinctions:

  • Melatonin: A physiological hormone rather than a sedative. Primarily regulates circadian rhythm. EMA-approved for short-term treatment of insomnia in patients over 55, and for jet lag. Lower dependence risk than Z-drugs.
  • Zopiclone: A cyclopyrrolone that enhances GABA activity, producing sedation. Standard prescription duration is typically 2–4 weeks. Carries risks of tolerance, dependence, and morning residual sedation.
  • Zolpidem: An imidazopyridine with similar mechanism to zopiclone. Sleep-onset focused. European regulators have lowered recommended doses (particularly for women) due to next-morning impairment data.

Cum puteți obține tratamente online

Prescrivia funcționează ca intermediar tehnologic: nu prescriem medicamente, nu angajăm medici și nu vindem medicamente. Platforma noastră conectează pacienții cu medici independenți înregistrați în UE, care pot efectua evaluări medicale online confidențiale.

Procesul este următorul:

  1. Completați un chestionar medical — Answer a structured set of medical questions covering your sleep patterns, duration of difficulties, sleep environment, mental health history, current medications, and any previous treatment for sleep disorders.

  2. Independent doctor review — An independent EU-registered doctor reviews your assessment. If a prescription sleep medication is clinically appropriate for a short-term period, the doctor may issue a prescription. If other factors indicate a different approach is warranted, the doctor will advise accordingly.

  3. Prescripție și livrare — If a prescription is issued, it is passed to a licensed EU pharmacy partner. The pharmacy dispenses the medication and arranges delivery to your address.

Important: Prescrivia nu garantează că o prescripție va fi emisă. Toate deciziile de prescriere sunt luate independent de medici calificați, pe baza circumstanțelor dumneavoastră clinice individuale. Z-drugs are controlled substances in many EU member states and are subject to strict prescribing restrictions.

Cum ne comparăm

Prin PrescriviaConsultație medicală în persoană
Disponibilitate24/7 online assessmentSubject to appointment availability
Timp de așteptareAssessment reviewed within hoursDays to weeks depending on location
Deplasare necesarăNoYes
Decizia de prescriereMade by independent EU-registered doctorMade by your GP
Ongoing monitoringSupported via follow-up assessmentsManaged by your GP
CostTransparent pricing displayed upfrontVaries by country and healthcare system

Note: Sleep disorders associated with sleep apnoea, restless legs syndrome, narcolepsy, or significant psychiatric comorbidity require specialist evaluation. Prescrivia’s platform is designed for adults with primary short-term insomnia suitable for remote assessment. Long-term management of chronic insomnia should ideally involve CBT-I delivered by a qualified practitioner.

Surse

Informațiile medicale de pe această pagină se bazează pe următoarele surse:

  • European Medicines Agency (EMA). Circadin (melatonin) — Summary of Product Characteristics. Available at: ema.europa.eu
  • Riemann D, et al. European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research. 2017;26(6):675-700.
  • World Health Organization (WHO). Sleep and health — WHO Fact Sheet. who.int

Acest conținut este revizuit periodic pentru a reflecta ghidurile clinice actualizate. Este furnizat exclusiv în scop informativ și nu constituie sfat medical. Consultați întotdeauna un profesionist medical calificat pentru sfaturi relevante pentru circumstanțele dumneavoastră individuale de sănătate.

Frequently asked questions

Pot obține Tulburări de somn online în Europa?
Puteți accesa acest medicament prin platforme intermediare online care vă conectează cu medici independenți înregistrați în UE. După completarea unui chestionar medical confidențial, un medic va evalua dacă medicamentul este adecvat clinic pentru dumneavoastră.
Care este diferența between melatonin and zopiclone or zolpidem?
Melatonin is a hormone naturally produced by the body that regulates the sleep-wake cycle. Prescription melatonin is primarily used for circadian rhythm disturbances and jet lag, and for older adults with insomnia. Zopiclone and zolpidem are sedative-hypnotic drugs (Z-drugs) that act on GABA receptors to induce sleep. They are more potent and carry greater risk of dependence.
Cât timp can I take zopiclone or zolpidem?
Z-drugs such as zopiclone and zolpidem are generally recommended for short-term use only — typically 2 to 4 weeks — due to risks of tolerance, dependence, and withdrawal. European clinical guidelines recommend cognitive behavioural therapy for insomnia (CBT-I) as the first-line treatment for chronic insomnia.
Is melatonin available without a prescription in Europe?
Melatonin's regulatory status varies across EU member states. In some countries it is available as an over-the-counter supplement; in others, including Germany and Ireland, prescription-strength melatonin requires a doctor's prescription. An independent doctor can assess what is appropriate for your situation.
What information do I need to provide for a sleep disorder assessment?
You will typically be asked about the nature of your sleep difficulties, how long they have persisted, any identified triggers, your current medications, medical history (including mental health history), and whether you have been evaluated for conditions such as sleep apnoea. This allows the reviewing doctor to make a safe clinical decision.
Prescrivia este doar o platformă intermediară. Nu furnizăm servicii medicale, nu prescriem tratamente și nu eliberăm medicamente. Toate deciziile medicale sunt luate de medici independenți înregistrați în UE. Toate medicamentele sunt eliberate de farmacii licențiate din UE. Această platformă facilitează legătura între pacienți și furnizorii de servicii medicale.

Written by Prescrivia Editorial. Medical information sourced from European Medicines Agency (EMA), World Health Organization (WHO), and published clinical data.

This content is informational only and does not constitute medical advice.

Last updated:

Sunteți gata să începeți?

Completați o evaluare de sănătate confidențială în aproximativ 3 minute.